Lv11
100 积分 2025-06-09 加入
A Novel Peroxisome Proliferator-Activated Receptor Responsive Element-Luciferase Reporter Mouse Reveals Gender Specificity of Peroxisome Proliferator-Activated Receptor Activity in Liver
1小时前
待确认
Global research trends and hotspots in targeted therapy for IgA nephropathy: a bibliometric and visualization analysis (1999–2025)
12天前
已完结
The impact of chiglitazar, a pan-PPAR agonist, on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: a real-world study
1个月前
已完结
Drugs targeting peroxisome proliferator-activated receptors
1个月前
已完结
Chiglitazar: First Approval
1个月前
已完结
NK2R agonist delivers one-two punch to obesity
2个月前
已完结
A Novel Peroxisome Proliferator-Activated Receptor Responsive Element-Luciferase Reporter Mouse Reveals Gender Specificity of Peroxisome Proliferator-Activated Receptor Activity in Liver
3个月前
已完结
TERN-501, a potent and selective agonist of thyroid hormone receptor beta, strongly reduces histological features and biomarkers of non-alcoholic steatohepatitis associated pathology in rodent models
4个月前
已完结
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis
4个月前
已完结
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
4个月前
已完结
皖公网安备34019202002308
